trending Market Intelligence /marketintelligence/en/news-insights/trending/Lx3kJnTc-SGzyqfcM94RDw2 content esgSubNav
In This List

Health Canada approves Pediapharm ear infection drug

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Health Canada approves Pediapharm ear infection drug

Health Canada approved Pediapharm Inc.'s Otixal for the treatment of acute otitis media with tympanostomy tubes in pediatric patients.

Otixal is an antibiotic and steroid combination ear drop.